PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 21(Suppl_3): 75-79 2001
© 2001 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Correa-Rotter, R
Right arrow Articles by Cueto-Manzano, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Correa-Rotter, R
Right arrow Articles by Cueto-Manzano, A
Peritoneal Dialysis International, Vol 21, Issue Suppl_3, S75-S79
Copyright © 2001 by International Society for Peritoneal Dialysis


Articles

The problem of the high transporter: is survival decreased?

R Correa-Rotter and A Cueto-Manzano

Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico. jcorrea@prodigy.net.mx

The mechanisms responsible for the problem status of high transporters are diverse. High transporters have increased protein losses that may play a role in the presence of hypoalbuminemia and malnutrition. On the other hand, high transport induces increased glucose absorption, which may in turn be responsible for anorexia and increased atherogenesis--issues not discussed here, but clearly of major importance. And finally, the impaired ultrafiltration present in the high transporter leads to fluid overload, which is one of the driving forces for ventricular hypertrophy, hypertension, and increased cardiovascular risk--cardiovascular events being most prevalent cause of death in dialysis patients. All of the factors previously discussed--and others--may preclude some high transporters from being good candidates for peritoneal dialysis. Yet many others may still do well if the prescription is individually tailored to the particular patient.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
K.-H. Oh, J.-Y. Moon, J. Oh, S. G. Kim, Y.-H. Hwang, S. Kim, J. S. Lee, and C. Ahn
Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2356 - 2364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2001 by Multimed Inc.